Ingevity (NYSE: NGVT) recently received a number of ratings updates from brokerages and research firms:
- 12/19/2025 – Ingevity had its price target raised by analysts at Wells Fargo & Company from $55.00 to $60.00. They now have an “equal weight” rating on the stock.
- 12/16/2025 – Ingevity was upgraded by analysts at Zacks Research to a “hold” rating.
- 12/10/2025 – Ingevity had its price target raised by analysts at BMO Capital Markets from $64.00 to $70.00. They now have an “outperform” rating on the stock.
- 12/6/2025 – Ingevity was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
- 11/12/2025 – Ingevity had its price target raised by analysts at Wells Fargo & Company from $52.00 to $55.00. They now have an “equal weight” rating on the stock.
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Further Reading
- Five stocks we like better than Ingevity
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Can Any Expenses Be Deducted From Capital Gains Tax?
- The Last Gold Bull Market
Receive News & Ratings for Ingevity Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
